Carregant...

A pilot study of single-dose azithromycin versus three-day azithromycin or single-dose ceftriaxone for uncomplicated acute otitis media in children()

Background: The pharmacokinetic profile of azithromycin supports its use as single-dose therapy for uncomplicated acute otitis media (AOM) in children. Objective: This study was designed to (1) compare the safety of single-dose oral azithromycin, 3 daily doses of oral azithromycin, and a single dose...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Arguedas, Adriano, Loaiza, Cecilia, Perez, Alexandra, Gutierrez, Alvaro, Herrera, Marco Luis, Rothermel, Constance D
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2003
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4061967/
https://ncbi.nlm.nih.gov/pubmed/24944350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.curtheres.2003.09.005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!